Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 10.10
-0.20 (-1.94%)
Sep 9, 2026, 4:00 PM EDT
Newland Pharmaceutical Revenue
Newland Pharmaceutical had revenue of 190.03M CNY in the quarter ending June 30, 2026, with 36.69% growth. This brings the company's revenue in the last twelve months to 710.55M, up 3.20% year-over-year. In the year 2025, Newland Pharmaceutical had annual revenue of 672.38M, down -7.44%.
Revenue (ttm)
710.55M
Revenue Growth
+3.20%
P/S Ratio
5.57
Revenue / Employee
724.31K
Employees
981
Market Cap
3.96B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 672.38M | -54.06M | -7.44% |
| Dec 31, 2024 | 726.44M | 75.00M | 11.51% |
| Dec 31, 2023 | 651.44M | 24.07M | 3.84% |
| Jan 1, 2023 | 627.36M | 113.53M | 22.09% |
| Jan 1, 2022 | 513.84M | 80.71M | 18.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.18B |
| Jinhe Biotechnology CO., LTD. | 2.94B |
| Zhejiang Starry Pharmaceutical | 2.46B |
| Tibet Weixinkang Medicine | 1.13B |
| Harbin Medisan Pharmaceutical | 805.09M |
| Shandong Wohua Pharmaceutical | 784.94M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 737.90M |
| Shanghai Xiao Fang Pharmaceutical | 541.90M |